SHM Supports the Mainstreaming Addiction Treatment Act
The Mainstreaming Addiction Treatment Act (H.R. 2482) will increase access to buprenorphine, a lifesaving addiction treatment, by eliminating the "X Waiver" DEA certificate and the
Your Browser Is No Longer Supported. Please upgrade your browser from Internet Explorer 10 to Internet Explorer 11 or higher
The Mainstreaming Addiction Treatment Act (H.R. 2482) will increase access to buprenorphine, a lifesaving addiction treatment, by eliminating the "X Waiver" DEA certificate and the
The Mainstreaming Addiction Treatment Act (S. 2074) is the companion bill to H.R. 2482. This bill will increase access to buprenorphine, a lifesaving addiction treatment, by eliminating the "X
SHM sent a support letter to Reps. Blumenauer and Mullin for their legislation, the Overdose Prevention and Patient Safety Act.
SHM submitted comments on the 2022 Inpatient Perspective Payment System Rule.
SHM responded to CMS' Request for Information (RFI) regarding their "Patients Over Paperwork" Initiative. We addressed excessive administrative burden related to observation care, the
SHM, along with other professional and medical societies, supports the Improving Timely Access to Care Act of 2019 (HR 3107). This bill will standardize prior authorization under Medicare
SHM submitted comments on the Hospital Outpatient Prospective Payment System proposed rule.
SHM submitted comments to CMS on the 2020 Physician Fee Schedule Proposed Rule. Comment areas include proposed changes to the Quality Reporting Program, physician assistant supervision, and
Comments on CY 2015 Physician Fee Schedule Proposed Rule - September 2 _blank
SHM Signs onto AHRQ Multi-Stakeholder Letter to House and Senate (senate)